How Healthcare Leaders Are Reacting to the Supreme Court Preserving Abortion Pill Access

Posted
The Supreme Court sided with the FDA and unanimously ruled to uphold access to abortion pill mifepristone. The decision quells worries about what it might look like if the Supreme Court sided with the physician group — many healthcare leaders feared that if the top court could overturn mifepristone’s FDA approval, the same could happen to other drugs. The post How Healthcare Leaders Are Reacting to the Supreme Court Preserving Abortion Pill Access appeared first on MedCity News.

Continue reading at MedCity News »

Legal, Providers, abortion drugs, abortion law, AMA, American Academy of Family Physicians, American Medical Association, FDA, mifepristone, supreme court, Wisp